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Encyclopaedia of Antibiotics, compiled by J. S. 
Glasby, is intended to provide a reference text for 
workers in organic hemistry, biochemistry, medicine 
and microbiology and in addition it could prove use- 
ful for practising pharmacologists. The author includes 
in his survey substances derived from or produced by 
a living organism and capable of inhibiting the life 
processes of microorganisms when present in small 
concentrations (Benedict and Langlyke), substances 
obtained from plants and higher organisms which 
possess antibiotic-like properties and substances active, 
almost exclusively, against carcinomas where no 
direct action due to microorganisms has yet been con- 
clusively proved. The text of 372 pages lists in the 
region of 1500 antibiotics and one must congratulate 
the author on even attempting what must have been 
an arduous task of compilation. It is a sobering thought 
that as the author himself observes the text, although 
very comprehensive, inevitably has many omissions 
particularly since new antibiotics are constantly being 
discovered. 
When first presented with such a lengthy choice of 
compounds it is perhaps natural to look up an anti- 
biotic with which one is familiar in an attempt o 
assess the criteria used for the purpose of selecting 
and describing agiven entry. Reference to chloram- 
phenicol, for example, reveals the chemical structure 
of the compound, adescription of its source and pre- 
paration and many chemical and physical properties 
possessed by the drug. Information is provided con- 
cerning which bacteria re inhibited by chloram- 
phenicol and what antibiotic concentrations are 
required to produce an inhibitory response. It also 
becomes apparent from the text that the drug is effec- 
tive versus Rocky Mountain spotted fever and may 
well afford protection against Democentroxenus 
rickettsi. So far so good for the organic hemist, the 
microbiologist and possible the medical gentleman. 
Sadly, however, the latter and the pharmacologist can 
not learn from the text of the known toxic side 
effects of this drug on bone marrow, occasionally seen 
during or following treatment of patients with chlor- 
amphenicol, but instead we are told that no toxic 
symptoms occur when patients are given a single dose 
of 2 g or 1 g daily for 10 days. It is likely too that 
many biochemists would be interested to know that 
chloramphenicol is a most effective inhibitor of the 
peptidyl transferase. centre of bacterial ribosomes - 
this being its main site of action and providing the 
reason for the specificity of the drug as an inhibitor 
of bacterial cells since no corresponding inhibitory 
action is observed on ribosomes from eukaryotes. 
With tetracycline we are indeed told of the side 
effects that this antibiotic can induce when admini- 
stered in attempts to control bacterial infections. But 
the biochemist is again left largely to ponder unaided 
although it is well known that this drug inhibits the 
binding of aminoacyl-tRNA to ribosomes from both 
pro- and eukaryotic ells. Tetracycline is an effective 
and specific antimicrobial agent only because for- 
tuitously it can penetrate animal cells only poorly 
whereas it is rapidly and actively transported into 
intact bacteria to give a high intracellular concentra- 
tion. 
It could be argued of course that detailed escrip- 
tions of the mode of action of antibiotics at the 
molecular level might interest only a few specialists in
this field despite the fact that such knowledge has 
often provided the basis for a rational chemotherapy 
involving design and use of new antibiotics. The point 
in question does, however, serve to illustrate a certain 
inconsistency apparent within the text of this encyclo- 
paedia. For example, with actinomycin D, admirably 
the relevant passage describes details of how this drug 
intercalates with DNA and in doing so inhibits DNA- 
dependent RNA synthesis and the section on this drug 
closes with the citation of no fewer than 75 references. 
As the author says actinomycin D is an effective 
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antitumour agent particularly in the treatment of a 
renal tumour in children (Wilm’s tumour) but it must 
be admitted that its clinical use is very limited and 
the main interest in the drug stems more from its use 
as a research tool to probe the mechanism of DNA- 
dependent RNA synthesis, This lack of balance in the 
text is also apparent elsewhere. Thus for gougerotin, a
drug of little or no use clinically and poorly charac- 
terised biochemically, the short description does tell 
us that the antibiotic inhibits protein synthesis by 
preventing transfer of amino acids from aminoacyl- 
tRNA intopolypeptide. In contrast, although penicillin 
was the first antibiotic to be discovered and used and 
still remains unrivalled for treatment of bacterial 
infections in general, we are told nothing concerning 
its mode of action involving interference with the cor- 
rect assembly of bacterial cell walls and the reference 
list provided is brief, particularly in relation to that 
cited for actinomycin D. In short a reader who wishes 
to refer to a given antibiotic in this volume may or 
may not find the information he seeks. 
Despite these rather specific criticisms, which I am 
of the opinion do cause an unfortunate lack of con- 
sistency in the coverage of the drugs elected, the 
volume has been compiled with great care and the 
presentation isvery clear. The names listed are often 
splendid with such gems as jolipeptin, kuwaitimycin, 
bramycin and virginiamycin to name but a few. What 
a disappointment to find 305 drugs called simply 
antibiotic, the name accompanied by letters or 
numbers or both. Perhaps in some cases the original 
(exotic) Japanese nomenclature has no corresponding 
English equivalent. It is fascinating to flip through the 
pages of this encyclopaedia and note the vast struc- 
tural variety and complexity illustrated by the anti- 
biotics selected. This aspect is surely the strength of 
the encyclopaedia as a reference book and having 
examined some of the structures depicted in detail I
for one am anxious to obtain many of these com- 
pounds with a view to carrying out further biochemical 
analysis. Such studies must surely give a wealth of 
information concerning structure-function relation- 
ships in the antibiotic field and it may be that a future 
massive volume compiled by the present author could 
incorporate many remarkable but hitherto undis- 
covered facts concerning the modes of inhibitory 
action of many of the compounds presently listed. 
Michael Cannon 
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The metabolism of aromatic ompounds i  of con- 
siderable intrinsic interest and importance since the 
metabolic reactions include the biosynthesis or degra- 
dation of a variety of different biologically important 
compounds, uch as the aromatic amino acids, some 
hormones particularly catecholamines and thyroxine, 
and foreign compounds, including many drugs and 
carcinogens. Although there are a number of excellent 
reviews covering these topics, this comprehensive 
treatise is a useful reference book, which can be used 
readily as a guide to the original literature on the inter- 
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mediary metabolism of aromatic ompounds. 
The book is divided into two sections. Part I (137 
pages) covers briefly the main reactions and enzymes, 
grouped together under convenient headings such as 
‘Reactions involving the formation and degradation 
of the aromatic nucleus and other ring systems’ and 
‘Formation and degradation of side-chains’. In part II 
(648 pages), some 7000 aromatic ompounds are 
listed alphabetically with information about their pre- 
cursors and/or degradation products. In the latter case, 
the species in which the relevant reactions have been 
